Patients and Caregivers.
A potential new solution.
Olema is committed to partnering with patients to develop new, effective therapies for women’s cancers. Before a new therapy can be made available to the general public, multiple studies involving patient volunteers must be conducted to evaluate the safety and effectiveness of the therapy.
These studies, referred to as clinical trials, are regulated by the Food and Drug Administration (FDA) in the United States and by similar regulatory agencies worldwide.